MicroRNA‐492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas
M Liu, J An, M Huang, L Wang, B Tu… - Molecular …, 2018 - Wiley Online Library
MicroRNAs (miRNAs) are small non‐coding RNA that target protein‐coding mRNAs at the
post‐transcriptional level. The aim of this study was to define the role of miR‐492 in cervical …
post‐transcriptional level. The aim of this study was to define the role of miR‐492 in cervical …
[HTML][HTML] Prognostic nomograms predicting survival in patients with locally advanced cervical squamous cell carcinoma: the first nomogram compared with revised …
…, J An, Y Zhang, Y Yang, S Chen, M Huang… - Frontiers in …, 2020 - frontiersin.org
Objectives To develop nomograms to assess prognostic factors for 5-year overall survival (OS)
and 5-year progression-free survival (PFS) in locally advanced cervical squamous cell …
and 5-year progression-free survival (PFS) in locally advanced cervical squamous cell …
[HTML][HTML] Long-term survival and late toxicity associated with pelvic intensity modulated radiation therapy (IMRT) for cervical cancer involving CT-based positive lymph …
C Lei, S Ma, M Huang, J An, B Liang, J Dai… - Frontiers in oncology, 2019 - frontiersin.org
The purpose of this study was to evaluate the outcomes and toxicity experienced by cervical
cancer patients with positive lymph nodes (LNs) who were treated with intensity-modulated …
cancer patients with positive lymph nodes (LNs) who were treated with intensity-modulated …
A phase 2 study of nanoparticle albumin‐bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma
Y Li, J Zeng, M Huang, J An, P Bai, L Wu, R Zhang - Cancer, 2017 - Wiley Online Library
BACKGROUND Nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) and nedaplatin (NDP)
are used for the treatment of patients with cervical cancer. However, to the authors’ …
are used for the treatment of patients with cervical cancer. However, to the authors’ …
[HTML][HTML] The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy
…, W Huang, J Liu, C Wang, M Huang… - … Journal of Medical …, 2022 - ncbi.nlm.nih.gov
Human fibroleukin 2 (Fgl2), a member of the fibrinogen superfamily, can cleave prothrombin
to generate thrombin or is secreted in a soluble form as a new type of effector of Tregs with …
to generate thrombin or is secreted in a soluble form as a new type of effector of Tregs with …
[HTML][HTML] Nomograms based on HPV load for predicting survival in cervical squamous cell carcinoma: An observational study with a long-term follow-up
…, Y Huang, J An, X Yang, N Li, M Huang… - Chinese Journal of …, 2019 - ncbi.nlm.nih.gov
Objective To investigate the prognostic value of pretreatment human papillomavirus (HPV)
viral load for cervical cancer, and to develop nomograms based on HPV load and other …
viral load for cervical cancer, and to develop nomograms based on HPV load and other …
Therapeutic strategy analysis of patients with advanced stage high‐grade neuroendocrine cervical cancer: A real‐world multicenter study
Y Zhang, Y Huang, S Luo, L Li, H Yang… - … of Gynecology & …, 2022 - Wiley Online Library
Objective To explore the management of high‐grade neuroendocrine cervical cancer (HGNECC)
since there has been no standard treatment for it. Methods Data on the management of …
since there has been no standard treatment for it. Methods Data on the management of …
[HTML][HTML] Serum microRNAs related with chemoradiotherapy resistance in advanced-stage cervical squamous cell carcinoma
Y Han, M Liu, Z Wang, M Huang, N Xu, L Wu - Translational oncology, 2017 - Elsevier
OBJECTIVE: To investigate the serum microRNAs as biomarkers in predicting chemoradiotherapy
resistance in advanced-stage cervical squamous cell carcinoma (ACSCC) patients. …
resistance in advanced-stage cervical squamous cell carcinoma (ACSCC) patients. …
[HTML][HTML] A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
G Yuan, L Wu, M Huang, N Li, J An - Radiation oncology, 2014 - Springer
Background To evaluate the efficacy and safety of concurrent chemo-radiotherapy with weekly
nedaplatin for the treatment of advanced squamous cell carcinoma of the uterine cervix. …
nedaplatin for the treatment of advanced squamous cell carcinoma of the uterine cervix. …
A fixed-jaw method to protect critical organs during intensity-modulated radiotherapy
J Chen, X Chen, M Huang, J Dai - Medical Dosimetry, 2014 - Elsevier
Intensity-modulated radiotherapy (IMRT) plays an important role in cancer radiotherapy. For
some patients being treated with IMRT, the extremely low tolerances of critical organs (such …
some patients being treated with IMRT, the extremely low tolerances of critical organs (such …